Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:NKONYSE:PLXNASDAQ:SFTNYSE:TVL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNKONiko ResourcesC$0.00C$0.01▼C$0.12C$1.88MN/A466,121 shs3.98 million shsPLXProtalix BioTherapeutics$2.85-3.1%$2.45$0.82▼$3.04$229.42M0.46468,153 shs795,410 shsSFTShift Technologies$0.99$0.10▼$5.90$2.90M1.581.81 million shs178.35 million shsTVLLIN Media$0.00$0.00▼$0.00N/AN/AN/A85,500 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNKONiko Resources0.00%0.00%0.00%0.00%0.00%PLXProtalix BioTherapeutics-1.52%+11.69%+15.22%+18.50%+140.91%SFTShift Technologies0.00%0.00%0.00%0.00%0.00%TVLLIN Media0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNKONiko ResourcesN/AN/AN/AN/AN/AN/AN/AN/APLXProtalix BioTherapeutics1.9635 of 5 stars3.50.00.00.01.10.01.9SFTShift TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ATVLLIN MediaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNKONiko Resources 0.00N/AN/AN/APLXProtalix BioTherapeutics 3.00Buy$15.00426.32% UpsideSFTShift Technologies 0.00N/AN/AN/ATVLLIN Media 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TVL, SFT, NKO, and PLX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/3/2025PLXProtalix BioTherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$10.00 ➝ $15.00(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNKONiko ResourcesC$13.23M0.00N/A0.37C($4.06) per share0.00PLXProtalix BioTherapeutics$53.40M4.16$0.16 per share17.80$0.47 per share6.06SFTShift Technologies$328.81M0.00N/AN/A($3.47) per share0.00TVLLIN MediaN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNKONiko ResourcesN/A-C$0.86N/AN/AN/AN/AN/AN/AN/APLXProtalix BioTherapeutics$8.31M$0.03N/A9.19N/A-21.03%-30.89%-11.74%N/ASFTShift Technologies-$172.04M-$12.31N/AN/AN/A-41.12%N/A-90.54%N/ATVLLIN MediaN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNKONiko ResourcesN/AN/AN/AN/AN/APLXProtalix BioTherapeuticsN/AN/AN/AN/AN/ASFTShift TechnologiesN/AN/AN/AN/AN/ATVLLIN MediaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNKONiko ResourcesN/A0.010.01PLXProtalix BioTherapeuticsN/A1.981.27SFTShift TechnologiesN/A1.330.92TVLLIN MediaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNKONiko ResourcesN/APLXProtalix BioTherapeutics16.53%SFTShift Technologies11.34%TVLLIN MediaN/AInsider OwnershipCompanyInsider OwnershipNKONiko ResourcesN/APLXProtalix BioTherapeutics6.30%SFTShift Technologies11.40%TVLLIN MediaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNKONiko ResourcesN/A94.05 millionN/ANot OptionablePLXProtalix BioTherapeutics20078.03 million69.00 millionOptionableSFTShift Technologies46417.00 million15.06 millionOptionableTVLLIN MediaN/AN/AN/ANot OptionableTVL, SFT, NKO, and PLX HeadlinesRecent News About These CompaniesTaiwan's Lin is eligible for event, says World BoxingNovember 28, 2024 | reuters.comImane Khelif hits back at Trump and Meloni: ‘Politicians speak without basis’November 14, 2024 | yahoo.comLiberty Media Announces Leadership Change and Strategic ShiftNovember 14, 2024 | markets.businessinsider.comLouisiana Film & TV Tax Credits On The Line As Lawmakers Consider Abolishing IncentiveNovember 13, 2024 | msn.comHow New PopSockets CEO Jiayu Lin Wants To Build A ‘Beloved Lifestyle Brand’November 13, 2024 | forbes.com‘Blue Bloods’ actress Lori Loughlin takes a page from Martha Stewart’s post-prison playbook: expertNovember 9, 2024 | msn.comDiscuss how AI is impacting media (and the election too)November 9, 2024 | technical.lyFascination with unconventional animals drawing young Chinese to pet cafes and social mediaNovember 8, 2024 | straitstimes.comGomulira villagers demand Govt intervention in Lin’s dubious land occupationNovember 7, 2024 | nyasatimes.com‘Tracker’ Takes No. 1 on Linear TV Chart for a 2nd Week — A Rare Feat for Scripted SeriesNovember 7, 2024 | msn.comTurn your TV into the ultimate media center with the Amazon Fire TV Stick 4kNovember 7, 2024 | miamiherald.com“Couldn’t Allow That”: How Jeremy Lin’s ‘Linsanity’ Hype Led Rajon Rondo to Have the Best Game of His Career in 2012November 7, 2024 | thesportsrush.comPiracy, original content, and AI: The sports media trends from SportelNovember 5, 2024 | sportspromedia.comTrump’s closing ad features debunked claim about Olympic boxerNovember 5, 2024 | msn.comNew November TV Releases: ‘Dune: Prophecy,’ ‘Arcane,’ ‘Outlander,’ ‘Cobra Kai,’ and MoreNovember 4, 2024 | collider.comUkraine reports first clash with North Korean troops in Kursk regionNovember 4, 2024 | msn.comJohn Legend, Ice-T, Michael Caine, and more pay tribute to Quincy Jones: 'A genius has left us'November 4, 2024 | msn.comWWE Superstars Reveal Their Amazing 2024 Halloween CostumesNovember 1, 2024 | comicbook.comHauppauge's Lori Loughlin returns to series TV in Prime Video police drama 'On Call'October 31, 2024 | newsday.comNovember TV Preview: 12 New Shows to WatchOctober 31, 2024 | indiewire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Tech Sell-Off Makes Microsoft Stock Look Like a StealBy Chris Markoch | April 1, 2025View Tech Sell-Off Makes Microsoft Stock Look Like a StealMicrosoft’s Big Malaysia Bet Could Pay Off for InvestorsBy Chris Markoch | March 28, 2025View Microsoft’s Big Malaysia Bet Could Pay Off for InvestorsInvestors Sell Microsoft Stock on OpenAI News—Time to Buy? By Chris Markoch | April 22, 2025View Investors Sell Microsoft Stock on OpenAI News—Time to Buy? Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop?By Chris Markoch | April 9, 2025View Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop?TVL, SFT, NKO, and PLX Company DescriptionsNiko Resources TSE:NKONiko Resources Ltd. engages in the exploration, development, and production of oil and natural gas in India and Bangladesh. It primarily holds interests in the D6 Block consisting of Dhirubhai 1 and 3 Fields, MA Field, R cluster development project, satellite cluster development project, and MJ field development project located off the coastline of Andhra Pradesh, India; and the Block 9 in the central area of Bangladesh. The company was founded in 1987 and is headquartered in Calgary, Canada.Protalix BioTherapeutics NYSE:PLX$2.85 -0.09 (-3.06%) Closing price 04:00 PM EasternExtended Trading$2.86 +0.00 (+0.18%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.Shift Technologies NASDAQ:SFTShift Technologies, Inc., together with its subsidiaries, provides an ecommerce platform for buying and selling used cars in the United States. The company operates in two segments, Retail and Wholesale. It engages in the retail sale of used vehicles through its platform; and provides financing and vehicle protection products. The company also provides value-added products, such as vehicle service contracts, guaranteed asset protection waiver coverage, wheel and tire coverage, prepaid maintenance plans, and appearance protection plans. In addition, it is involved in the sale of used vehicles through wholesale auctions or directly to a wholesaler. The company was founded in 2013 and is headquartered in San Francisco, California.LIN Media NYSE:TVLLIN Media LLC (LIN Media) is a local multimedia company. The Company operates or services 43 television stations and seven digital channels in 23 of the United States markets, and a portfolio of Websites, applications and mobile products. Its television stations deliver local news, community service, and sports and entertainment programming to viewers, reaching 10.5% of homes owning televisions in the United States. In April 2013, it acquired a majority ownership position in HYFN. On July 30, 2013, LIN Media announced that it had completed its merger with LIN TV Corp., with LIN Media, as the surviving company in the merger. In February 2014, the Company acquired Federated Media Publishing, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
